ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
ConditionSudden Cardiac Arrest
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKestra Medical Technologies, Inc.
About this trial
Active surveillance study using real-world data collected in the ASSURE Patient Registry. Outcome measures are based on analysis of ASSURE Registry data including data recorded by the WCD then annotated by clinical experts in electrophysiology.
Eligibility criteria
Qualifiers
Adult patient prescribed the ASSURE wearable cardioverter defibrillator
Provided written informed consent to participate in the ASSURE Patient Registry
Disqualifiers
Patients who do not meet the Inclusion criteria
Trial design
Treatments tested in this trial
- Defibrillation
Treatment groups
5,179 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov